Bruker/$BRKR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Ticker
$BRKR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
11,396
ISIN
US1167941087
Website
Bruker Metrics
BasicAdvanced
$5.7B
71.80
$0.52
1.23
$0.20
0.53%
Price and volume
Market cap
$5.7B
Beta
1.23
52-week high
$70.58
52-week low
$34.10
Average daily volume
2.3M
Dividend rate
$0.20
Financial strength
Current ratio
1.57
Quick ratio
0.537
Long term debt to equity
112.149
Total debt to equity
114.185
Dividend payout ratio (TTM)
38.44%
Interest coverage (TTM)
6.69%
Management effectiveness
Return on assets (TTM)
4.79%
Return on equity (TTM)
4.76%
Valuation
Price to earnings (TTM)
71.8
Price to revenue (TTM)
1.647
Price to book
3.12
Price to tangible book (TTM)
-9.25
Price to free cash flow (TTM)
32.509
Dividend yield (TTM)
0.53%
Forward dividend yield
0.53%
Growth
Revenue change (TTM)
14.84%
Earnings per share change (TTM)
-80.80%
3-year revenue growth (CAGR)
11.92%
3-year earnings per share growth (CAGR)
-34.30%
3-year dividend per share growth (CAGR)
5.57%
What the Analysts think about Bruker
Analyst ratings (Buy, Hold, Sell) for Bruker stock.
Bruker Financial Performance
Revenues and expenses
Bruker Earnings Performance
Company profitability
Bruker News
AllArticlesVideos
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
Business Wire·3 days ago
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
Business Wire·5 days ago
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
Business Wire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jun16
Bruker
Dividend·Ex-dividend
Jun27
Bruker
Dividend·Payment
$0.05Per share
FAQs
What’s the current market cap for Bruker stock?
Bruker (BRKR) has a market cap of $5.7B as of June 07, 2025.
What is the P/E ratio for Bruker stock?
The price to earnings (P/E) ratio for Bruker (BRKR) stock is 71.8 as of June 07, 2025.
Does Bruker stock pay dividends?
Yes, the Bruker (BRKR) stock pays dividends to shareholders. As of June 07, 2025, the dividend rate is $0.2 and the yield is 0.53%. Bruker has a payout ratio of 38.44% on a trailing twelve-month basis.
When is the next Bruker dividend payment date?
The next Bruker (BRKR) dividend payment is scheduled for June 27, 2025.
What is the beta indicator for Bruker?
Bruker (BRKR) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.